The facility purifies and characterizes biologically active small molecules that have the potential to serve as drug leads.
Our expertise is in chemical genetics and microbiology – essentially, the production of biologically active small molecules by living systems and the interactions of those molecules with bacteria. We can culture a diverse array of environmental microorganisms, including both bacteria (predominantly streptomycetes and other closely related actinobacteria), and rare fungi (predominantly Cordyceps). We have developed culture conditions (chemical and genetic elicitation) that cause these microorganisms to express their ‘secondary metabolism’ to the fullest, thus permitting the detection and subsequent purification of diverse, biologically active molecules that can be used in drug discovery.
Small molecule purification and structural characterization
- Life sciences, pharmaceuticals and medical equipment
Specialized labs and equipment
Name of equipment in use | Description of function |
---|---|
Liquid chromatography/ mass spectrometry | Detection of small molecules by mass, light absorbance and hydrophobicity |
High-performance liquid chromatography x 2 | Purification of small molecules on the basis of structure and chemistry |
Private and public sector research partners
- PuraPharm Corporation
- Cubist Pharmaceuticals Inc.
- Merck
Additional information
Title | URL |
---|---|
Daniel-Ivad et al., 2017 | http://pubs.acs.org/doi/abs/10.1021/acschembio.6b01002 |
Pimentel-Elardo et al., 2015 | http://pubs.acs.org/doi/abs/10.1021/acschembio.5b00612 |